RNA m5C甲基化修饰及其检测技术在肿瘤中的研究进展
Research Progress of RNA m5C Methylation Modification and Its Detection Technology in Tumors
DOI: 10.12677/ACM.2022.126783, PDF,   
作者: 吴 念：重庆市第五人民医院，重庆；代 鑫, 龚建平*：重庆医科大学附属第二医院，重庆
关键词: RNA甲基化；5-甲基胞嘧啶；检测技术；肿瘤；RNA Methylation； 5-Methylcytosine； Detection Technology； Tumor
摘要: RNA甲基化修饰作为转录后修饰的重要组成部分，主要包括N6-甲基腺苷(m6A)、5-甲基胞嘧啶(m5C)、N1-甲基腺苷(m1A)三种修饰类型。以RNA亚硫酸氢盐测序(RNA-BisSeq)为代表的单碱基分辨率检测技术的发展推动了RNA m5C甲基化修饰的研究。由甲基转移酶、去甲基化酶以及甲基化识别蛋白三个主要成分构成的RNA m5C甲基化修饰调控网络，参与包括肿瘤在内的多种疾病的发生发展。本文综述了RNA甲基化修饰的类型、m5C甲基化检测技术的分类与进展及m5C动态调控网络参与肿瘤发生发展的最新研究进展，旨在为以RNA m5C调控网络为靶点的肿瘤治疗方案提供新思路。
Abstract: As an important part of post transcriptional modification, RNA methylation mainly includes N6-methyladenosine (m6A), 5-methylcytosine (m5C) and N1-methyladenosine (m1A). The devel-opment of single base resolution detection technology represented by RNA-BisSeq has promoted the research of RNA m5C methylation modification. The regulatory network of RNA m5C methyla-tion modification, which is composed of methyltransferase, demethylase and methylation recogni-tion protein, is involved in the occurrence and development of a variety of diseases, including tu-mors. This paper reviews the types of RNA methylation modification, the classification and progress of m5C methylation detection technology and the latest research progress of dynamic regulatory network involved in tumorigenesis and development, in order to provide new ideas for tumor treatment targeting RNA m5C regulatory network.
文章引用：吴念, 代鑫, 龚建平. RNA m5C甲基化修饰及其检测技术在肿瘤中的研究进展[J]. 临床医学进展, 2022, 12(6): 5407-5414. https://doi.org/10.12677/ACM.2022.126783

参考文献

[1] Nombela, P., Miguel-López, B., Blanco, S., et al. (2021) MODOMICS: A Database of RNA Modification Pathways. 2021 Update. Molecular Cancer, 20, 18. [Google Scholar] [CrossRef] [PubMed]
[2] Boccaletto, P., Stefan-iak, F., Ray, A., et al. (2022) MODOMICS: A Database of RNA Modification Pathways. 2021 Update. Nucleic Acids Research, 50, 231-235. [Google Scholar] [CrossRef] [PubMed]
[3] Roundtree, I.A., Evans, M.E., Pan, T., et al. (2017) Dynamic RNA Modifications in Gene Expression Regulation. Cell, 169, 1187-1200. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, T.Y., Kong, S., Tao, M., et al. (2020) The Potential Role of RNA N6-Methyladenosine in Cancer Progression. Molecular Cancer, 19, 88. [Google Scholar] [CrossRef] [PubMed]
[5] Bohnsack, K., Höbartne, C. and Bohnsack, M. (2019) Eukaryot-ic 5-methylcytosine (m5C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease. Genes, 10, 102. [Google Scholar] [CrossRef] [PubMed]
[6] Song, J., Zhai, J.J., Bian, E., et al. (2018) Transcriptome-Wide Annotation of m5C RNA Modifications Using Machine Learning. Frontiers in Plant Science, 9, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[7] Motorin, Y., Lyko, F. and Helm, M. (2009) 5-methylcytosine in RNA: Detection, Enzymatic Formation and Biological Functions. Nucleic Acids Research, 38, 1415-1430. [Google Scholar] [CrossRef] [PubMed]
[8] Frye, M., Drggoni, I., Chin, S.F., et al. (2010) Genomic Gain of 5p15 Leads to Over-Expression of Misu (NSUN2) in Breast Cancer. Cancer Letters, 289, 71-80. [Google Scholar] [CrossRef] [PubMed]
[9] Xiong, X.S., Li, X.Y., Yi, C.Q., et al. (2018) N1-methyladenosine Methylome in Messenger RNA and Non-Coding RNA. Current Opinion in Chemical Biology, 45, 179-186. [Google Scholar] [CrossRef] [PubMed]
[10] Dominissini, D., Nachtergaele, S., Sharon, M.M., et al. (2016) The Dynamic N1-Methyladenosine Methylome in Eukaryotic Messenger RNA. Nature, 530, 441-446. [Google Scholar] [CrossRef] [PubMed]
[11] Idaghdour, Y. and Hodgkinson, A. (2017) Integrated Genomic Analysis of Mitochondrial RNA Processing in Human Cancers. Genome Medicine, 9, 36. [Google Scholar] [CrossRef] [PubMed]
[12] Limbach, P.A. and Paulines, M.J. (2018) Going Global: The New Era of Mapping Modifications in RNA. WIREs RNA, 8, 1. [Google Scholar] [CrossRef] [PubMed]
[13] Cui, X.A., Liang, Z., Shen, L.S., et al. (2017) 5-Methylcytosine RNA Methylation in Arabidopsis Thaliana. Molecular Plant, 9, 13. [Google Scholar] [CrossRef] [PubMed]
[14] Hussain, S., Sajini, A.A., Blanco, S., et al. (2013) NSun2-Mediated Cytosine-5 Methylation of Vault Noncoding RNA Determines Its Processing into Regulatory Small RNAs. Cell Reports, 4, 255-261. [Google Scholar] [CrossRef] [PubMed]
[15] Haute, L.V., Lee, S.Y., McCann, B.J., et al. (2019) NSUN2 In-troduces 5-Methylcytosines in Mammalian Mitochondrial tRNAs. Nucleic Acids Research, 47, 8720-8733. [Google Scholar] [CrossRef] [PubMed]
[16] Trixl, L. and Lusser, A. (2019) The Dynamic RNA Modification 5-methylcytosine and Its Emerging Role as an Epitranscriptomic Mark. WIREs RNA, 10, 1510. [Google Scholar] [CrossRef] [PubMed]
[17] Khoddami, V. and Cairns, B.R. (2014) Transcriptome-Wide Target Profil-ing of RNA Cytosine Methyltransferases Using the Mechanism-Based Enrichment Procedure Aza-IP. Nature Protocols, 9, 337-361. [Google Scholar] [CrossRef] [PubMed]
[18] Khoddami, V. and Cairns, B.R. (2013) Identification of Direct Targets and Modified Bases of RNA Cytosine Methyltransferases. Nature Biotechnology, 31, 458-464. [Google Scholar] [CrossRef] [PubMed]
[19] Schaefer, M. (2013) RNA 5-Methylcytosine Analysis by Bisulfite Sequenc-ing. Methods in Molecular Biology, 1870, 237-248.
[20] Yuan, F., Bi, Y., Paulina, S.Z., et al. (2019) Bisulfite-Free and Base-Resolution Analysis of 5-Methylcytidine and 5-hydroxymethylcytidine in RNA with Peroxotungstate. ChemComm, 55, 2328-2331. [Google Scholar] [CrossRef] 
[21] Schumann, U., Zhang, H.N., Sibbritt, T., et al. (2020) Multiple Links between 5-methylcytosine Content of mRNA and Translation. BMC Biology, 18, Article No. 40. [Google Scholar] [CrossRef] [PubMed]
[22] Pan, J., Huang, Z.D., Xu, Y.Q., et al. (2021) m5C RNA Meth-ylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma. Frontiers in Oncology, 11, Article ID: 657466. [Google Scholar] [CrossRef] [PubMed]
[23] Yu, X., Zhang, Q.Y., Gao, F., et al. (2021) Predictive Value of m5C Regulatory Gene Expression in Pancreatic Adenocarcinoma. Scientific Reports, 11, Article No. 17529. [Google Scholar] [CrossRef] [PubMed]
[24] Blanco, S., Dietmann, S., Flores, J.V., et al. (2014) Aberrant Methylation of tRNAs Links Cellular Stress to Neuro-Developmental Disorders. EMBO Journal, 33, 2020-2039. [Google Scholar] [CrossRef] [PubMed]
[25] Ivanov, P., Emara, M.M., Villen, J., et al. (2011) Angiogen-in-Induced tRNA Fragments Inhibit Translation Initiation. Molecular Cell, 43, 613-623. [Google Scholar] [CrossRef] [PubMed]
[26] Blanco, S., Bandiera, R., Popis, M., et al. (2016) Stem Cell Function and Stress Response Are Controlled by Protein Synthesis. Nature, 534, 335-340. [Google Scholar] [CrossRef] [PubMed]
[27] Tuorto, F., Herbst, F., Alerasool, N., et al. (2015) The tRNA Methyl-transferase Dnmt2 Is Required for Accurate Polypeptide Synthesis during Haematopoiesis. EMBO Journal, 34, 2350-2362. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, W.G. (2016) mRNA Methylation by NSUN2 in Cell Proliferation. WIREs RNA, 7, 838-842. [Google Scholar] [CrossRef] [PubMed]
[29] Chen, X., Li, A., Sun, B.F., et al. (2019) 5-Methylcytosine Promotes Pathogenesis of Bladder Cancer through Stabilizing mRNAs. Nature Cell Biology, 21, 978-990. [Google Scholar] [CrossRef] [PubMed]
[30] Fu, L.J., Guerrero, C.R., Zhong, N., et al. (2014) Tet-Mediated Formation of 5-Hydroxymethylcytosine in RNA. Journal of the American Chemical Society, 136, 11582-11585. [Google Scholar] [CrossRef] [PubMed]
[31] Li, W. and Xu, L. (2019) Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies. Oncology Research and Treatment, 42, 309-318. [Google Scholar] [CrossRef] [PubMed]
[32] Takai, H., Masuda, K., Sato, T., et al. (2014) 5-Hydroxymethylcytosine Plays a Critical Role in Glioblastomagenesis by Recruiting the CHTOP-Methylosome Com-plex. Cell Reports, 9, 48-60. [Google Scholar] [CrossRef] [PubMed]
[33] Carella, A., Tejedor, J.R., García, M.G., et al. (2020) Epigenetic Downregulation of TET3 Reduces Genome-Wide 5hmC Levels and Promotes Glioblas-toma Tumorigenesis. International Journal of Cancer, 146, 373-387. [Google Scholar] [CrossRef] [PubMed]
[34] Yang, X., Yang, Y., Sun, B.F., et al. (2017) 5-Methylcytosine Promotes mRNA Export—NSUN2 as the Methyltransferase and ALYREF as an m5C Reader. Cell Research, 27, 606-625. [Google Scholar] [CrossRef] [PubMed]
[35] Dominissini, D. and Rechavi, G. (2017) 5-Methylcytosine Mediates Nu-clear Export of mRNA. Cell Research, 27, 717-719. [Google Scholar] [CrossRef] [PubMed]
[36] Yang, Y., Wang, L., Han, X., et al. (2019) RNA 5-Methylcytosine Facilitates the Maternal-to-Zygotic Transition by Preventing Maternal mRNA Decay. Molecular Cell, 75, 1188-1202. [Google Scholar] [CrossRef] [PubMed]
[37] Nagy, Z., Seneviratne, J.A., Kanikevich, M., et al. (2021) An ALYREF-MYCN Coactivator Complex Drives Neuroblastoma Tu-morigenesis through Effects on USP3 and MYCN Stability. Nature Communications, 2, Article No. 1881. [Google Scholar] [CrossRef] [PubMed]
[38] Wang, J.Z., Zhu, W., Han, J., et al. (2021) The Role of the HIF-1α/ALYREF/PKM2 Axis in Glycolysis and Tumorigenesis of Bladder Cancer. Cancer Communications, 41, 560-575. [Google Scholar] [CrossRef] [PubMed]
[39] Cheng, J.X., et al. (2018) RNA Cytosine Methylation and Me-thyltransferases Mediate Chromatin Organization and 5-Azacytidine Response and Resistance in Leukaemia. Nature Communications, 9, Article No. 1163. [Google Scholar] [CrossRef] [PubMed]
[40] Schaefer, M., Hagemann, S., Hanna, K., et al. (2009) Azacyti-dine Inhibits RNA Methylation at DNMT2 Target Sites in Human Cancer Cell Lines. Cancer Research, 69, 8127-8132. [Google Scholar] [CrossRef] 
[41] Sakita-Suto, S., Kanda, A., Suzuki, F.S., et al. (2007) Au-rora-B Regulates RNA Methyltransferase NSUN2. Molecular Biology of the Cell, 18, 1107-1117. [Google Scholar] [CrossRef] [PubMed]

为你推荐